The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

New drug for schizophrenics has experts excited Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. "This drug takes ...

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

The FDA has approved Bristol Myers Squibb’s new schizophrenia drug, Cobenfy, the first novel treatment for schizophrenia in over 70 years. Schizophrenia affects nearly 3 million U.S. adults, but only ...

A new tertiary treatment plant (TTP) and a state-of-the-art wetland have been set up at the Sector 54 sewage treatment plant complex, with an aim to ensure sustainable water management and ...

Despite the seriousness of this condition, treatment can make it possible for you or a loved one with schizophrenia to manage the symptoms and have meaningful relationships, go to work or school ...

The company will halt further development of luvadaxistat and focus on another schizophrenia candidate ... of subjects enrolled across the treatment arms. Also Read: Neurocrine Biosciences ...

"I think this was an unfortunate situation where that did not occur," Howell said of the speed Van Noy's treatment came, per ESPN. "Thank God for Kyle's situation [that] it wasn't worse.

we understand the challenges and hurdles that exist in identifying potential medicines for the treatment of cognitive impairment in schizophrenia. “We, therefore, plan to halt further ...

Neurocrine Biosciences said its trial of luvadaxistat as a potential treatment to improve cognitive impairment in patients with schizophrenia failed to meet its primary endpoint. The San Diego ...

A wheelchair racer from Coventry has thanked her family for their support during her Paralympic career. Karé Adenegan won two silver medals at the 2024 Paris Games, taking her total Paralympic ...

The extent of skin involvement and the severity of symptoms determine the stage, which helps guide the choice of treatment. Moderate psoriasis affects about 3% to 10% of the body surface and ...